Loraz and Benlysta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Benlysta (belimumab). Common drug interactions include blood potassium decreased among females and agitation among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Benlysta. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.

On Jul, 09, 2026

77 people who take Loraz and Benlysta together, and have interactions are studied.

What are the common drug interactions of Loraz and Benlysta, by gender? *:

female:

Blood potassium decreased
Eye disorder
Asthma
Balance disorder
Blood glucose decreased
Drug administration error
Foot deformity (functional disability of foot)
Infusion related reaction
Laceration (tearing of soft body tissue)
Pneumonia

male:

Agitation (state of anxiety or nervous excitement)
Cough
Abdominal pain upper
Apathy
Arthralgia (joint pain)
Confusional state
Dizziness
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Headache (pain in head)
Pain in extremity

What are the common drug interactions of Loraz and Benlysta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Infection

20-29:

n/a

30-39:

Arthralgia (joint pain)
Contusion (a type of hematoma of tissue in which capillaries)
Fatigue (feeling of tiredness)
Pain in extremity
Asthma
Balance disorder
Blood glucose decreased
Blood potassium decreased
Drug administration error
Eye disorder

40-49:

Headache (pain in head)
Migraine (headache)
Drug hypersensitivity
Ear injury
Gait disturbance
Mobility decreased (ability to move is reduced)
Otorrhoea (discharge from the ear)
Peripheral swelling
Swelling
Swelling face

50-59:

Muscle spasms (muscle contraction)
Muscular weakness (muscle weakness)
Neuropathy peripheral (surface nerve damage)
Osteonecrosis (death of bone)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Photophobia (extreme sensitivity to light)
Pleurisy (inflammation of the pleurae, which causes pain when breathing)
Pneumonia
Pruritus (severe itching of the skin)
Pruritus generalised (generalized itching)

60+:

Atelectasis (partial or complete collapse of the lung)
Dyspnoea (difficult or laboured respiration)
Pneumonia
Poor peripheral circulation
Surgery
Syncope (loss of consciousness with an inability to maintain postural tone)
Urinary retention (the inability to completely or partially empty the bladder)
Asthenia (weakness)
Diarrhoea
Rhinorrhoea (watery mucus discharge from the nose)

What are the existing conditions these people have? *

Pain: 7 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Benlysta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously